Review waiting, please be patient.
This may take 4 months or more, since drafts are reviewed in no specific order. There are 3,050 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Submission declined on 17 June 2024 by Twinkle1990 (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has been resubmitted and is currently awaiting re-review. |
Elva Díaz | |
---|---|
Born | San Jose, California, U.S. |
Citizenship | USA |
Occupation(s) | Pharmacology Professor and Researcher at UC Davis |
Academic background | |
Education | B.A., in Biochemical Sciences, 1993
Ph.D., in Biochemistry, 1999 Postdoc, in Developmental Neurobiology, 2003 |
Alma mater | Harvard University, B.A.
Stanford University, Ph.D. UC Berkeley, Postdoc |
Elva Díaz is a pharmacology[1][2] professor and researcher who specializes in developmental neurobiology. Her laboratory uses rodents to study molecular mechanisms of brain development.[3][4][5].
Elva Díaz was born to Mexican immigrant parents who moved to California during their childhood[6].
Díaz attended Harvard University for her undergraduate studies where she majored in Biomechanical Science[5] and earned a PhD in Biochemistry at Stanford University[5].
Díaz’s research focuses on the molecular mechanisms involved in the development, function, and plasticity of excitatory synapses in the central nervous system (CNS)[5]. Díaz is a recipient of the NIH Director’s New Innovator Award[7]
One of Díaz’s core areas of research involve the exploration of the potential of pluripotent stem cells combined with immunotherapy to treat brain cancers[3]. In her research she has identified that tumor cells in the brain form pseudo synapses with the CNS to take over nutrients and mimic normal cellular communications[3].
Elva Díaz also investigates the dynamics of AMPA-type glutamate receptors, key components in fast synaptic transmission essential for memory in the brain[8]. Díaz's team has identified a protein called SynDIG4 that regulates this receptor movement, potentially enhancing memory strength[8].
This submission has now been cleaned of the above-noted copyright violation and its history redacted by an administrator to remove the infringement. If re-submitted (and subsequent additions do not reintroduce copyright problems), the content may be assessed on other grounds.